Skip to main content

  • Wednesday, Jun 21st
    3:15 PM – 3:30 PM  
    CART-cell Therapy Directed Towards Novel CD84 Antigen for the Treatment of Acute Myeloid Leukemia
    Location: Salon A-D
    Presenting Author: Manel Juan, MD, PhD – Hospital Clinic de Barcelona
    Immuno-engineering and Cellular Therapies
  • Wednesday, Jun 21st
    4:00 PM – 4:15 PM  
    CRISPR/Cas9-Based Editing of KLRC1 Enhances the Efficacy of Primary CD33-Targeting CAR-NK Cells Against Acute Myeloid Leukemia
    Location: Salon A-D
    Presenting Author: Evelyn Ullrich, MD – Goethe University Frankfurt
    Immuno-engineering and Cellular Therapies
  • Wednesday, Jun 21st
    4:30 PM – 4:45 PM  
    Serum- and Feeder-Free Generation of CD4 Single Positive T Cells and Regulatory T Cells from Human Induced Pluripotent Stem Cells
    Location: Salon H-K
    Presenting Author: Helen Fong, PhD – Sangamo Therapeutics
    Immuno-engineering and Cellular Therapies
  • Wednesday, Jun 21st
    5:00 PM – 5:15 PM  
    Selective Depletion of Follicular Helper T Cells Using Chimeric Antigen Receptor Natural Killer Cells
    Location: Salon A-D
    Presenting Author: Nora Lakes – Cincinnati Children's Hospital Medical Center
    Immuno-engineering and Cellular Therapies
  • Thursday, Jun 22nd
    3:30 PM – 3:45 PM  
    A Biosensor of Immunologic Synapse Formation for Multiplexed T Cell Antigen Discovery
    Location: Salon F-G
    Presenting Author: Josiah Gerdts, MD PhD – University of California, San Francisco
    Immuno-engineering and Cellular Therapies